Citation Information :
Sagar VV, Acharya S, Agrawal G, Shukla S, Kumar S, Akhil CV. Hepatopulmonary Syndrome and Portopulmonary Hypertension Coexisting in a Case of Wilson's Disease Cirrhosis: “Double Trouble”. Indian J Respir Care 2022; 11 (2):176-180.
Wilson's disease is one of the infrequent causes of hepatic failure with a wide clinical spectrum. Hepatic and neuropsychiatric manifestations are the most common, whereas atypical presentations were also reported as the complications of hepatic failure such as hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH). These are considered pulmonary complications of hepatic disease with underlying complex pathology and various vasoactive substances such as endothelin 1 and nitric oxide on the pulmonary blood vessels. HPS usually presents with breathlessness and central cyanosis. The triad of HPS comprises dilatation of pulmonary vasculature, intrapulmonary shunting, and hypoxia, whereas POPH causes vasoconstriction and vascular remodeling leading to increased resistance in pulmonary blood vessels and subsequent right ventricular dysfunction. In this case report, we highlight two antagonistic pathological processes coexisting in the same patient.
Pham DM, Subramanian R, Parekh S. Coexisting hepatopulmonary syndrome and portopulmonary hypertension: Implications for liver transplantation. J Clin Gastroenterol 2010;44:e136-40.
Rezaeetalab F, Mozdourian M. Pulmonary hypertension as an initial presentation of Wilson's disease: A case report. Rev Clin Med 2020;6:178-81.
Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol 2014;20:8072-81.
Lahiri D, Agarwal R, Mondal D, Roy MK, Sarkar N, Mukhopadhyay J. Hepatopulmonary syndrome as the first manifestation of Wilson disease. JCR 2015;5:37-41.
Chávez-Tapia NC, Uribe M, López E. Pulmonary complications of liver cirrhosis: portopulmonary hypertension and hepatopulmonary syndrome. The paradox of pulmonary vasoconstriction and vasodilation. Gac MedMex 2007;143:333-9.
Restrepo R, Singer EF, Baram M, Restrepo R, Singer EF, Baram M. Hepatopulmonary syndrome and portopulmonary hypertension. Hosp Pract (1995) 2013;41:62-71.
Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension. Swiss Med Wkly 2003;133:163-9.
Ramsay MA. Portopulmonary hypertension and hepatopulmonary syndrome, and liver transplantation. Int Anesthesiol Clin 2006;44:69-82.
Mandell MS. Hepatopulmonary syndrome and portopulmonary hypertension in the Model for End-Stage Liver Disease (MELD) era. Liver Transpl 2004;10:S54-8.
Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: Implications for liver transplantation. Clin Chest Med 2005;26:587-97.
Le Pavec J, Souza R, Herve P, Lebrec D, Savale L, Tcherakian C, et al. Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med 2008;178:637-43. doi: 10.1164/rccm.200804-613OC. Epub 2008 Jul 10. PMID: 18617641.